Study Details

Back
Study ID E05-CL-3001
Study Title A Multicentre, Single-Arm, Open-Label Study of the Repeated Administration of QUTENZATM for the Treatment of Peripheral Neuropathic Pain (STRIDE)
Clinicaltrials.gov Identifier 1252160
Compound Name NGX-4010 (ASP0805) / capsaicin
Medical Indication or Disease Peripheral neuropathic pain
Study Sponsor Astellas Pharma Europe Ltd. (APEL)
Collaborator Not Applicable
Study Start Date 28-Oct-2010
Study Completion Date 26-Sep-2013
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS